341 patienter med type 2- diabetes blev i et randomiseret studie behandlet med enten NovoMix 30 alene eller i kombination med metformin, eller med metformin sammen med sulfonylurea.
In one study, 341 patients with type 2 diabetes were randomised to treatment with NovoMix 30 either alone or in combination with metformin, or to metformin together with sulfonylurea.